Clinical trial
Phase I-II Clinical Trial to Compare the Safety and Efficacy of Nanodrop® Against Systane® Balance in the Treatment of Dry Eye Patients
NCT04111965 is registered in ClinicalTrials.gov with Laboratorios Sophia S.A de C.V. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I-II Clinical Trial to Compare the Safety and Efficacy of Nanodrop® Against Systane® Balance in the Treatment of Dry Eye Patients
- Lead sponsor
- Laboratorios Sophia S.A de C.V.
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- December 1, 2020
- Completion date
- December 10, 2021
- Enrollment
- 126 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
dry eye